Now, Ranbaxy AIDS drug under US lens

A United States Congressional committee has widened the scope of its ongoing inquiry into the United States Food and Drug Administration’s (USFDA) handling of drug- marketing approvals of India’s

Cipla notice to US NGO on AIDS drug

New, more efficient anti-AIDS drug for untreated patients

Ranbaxy plans trials for new drug

Our drugs are safe and effective:Ranbaxy

Ranbaxy to demerge drug discovery operation

This entry was posted on Sunday, September 21st, 2008 at 4:40 am and is filed under Business Standard. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Indian Stock Market

Now, Ranbaxy AIDS drug under US lens

Leave a Reply

Categories

Archives

Feed

Links

Subscribe by E-Mail :

Recent Posts

Recent Comments

Indian Stock Market News